Pancreatic Cancer Research

ResearcherBC Cancer AgencyNo recent work listed

Charles David Blanke

Matched on ORCID iD 0000-0002-6493-7834; OpenAlex author ID A5037149615. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2002: 1 trial · 2003: none · 2004: none · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper

Papers 2

  1. Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomize… Co-author DOI 10.1001/jamaoncol.2016.5383↗
  2. Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized … Last author DOI 10.1002/cncr.28744↗

Trials 1

  1. Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer Principal investigator NCT00238199↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Lowy · 2 shared papers, 2014–2017 · strength 0.10
  2. Philip A. Philip · 2 shared papers, 2014–2017 · strength 0.10
  3. Andrew Eugene Hendifar · 1 shared paper, 2017 · strength 0.06
  4. Tara Elisabeth Seery · 1 shared paper, 2017 · strength 0.06
  5. Dana Backlund Cardin · 1 shared paper, 2017 · strength 0.06
  6. Vincent M. Chung · 1 shared paper, 2017 · strength 0.06
  7. Andrea Wang‐Gillam · 1 shared paper, 2017 · strength 0.06
  8. Howard S. Höchster · 1 shared paper, 2017 · strength 0.06
  9. Takeru Wakatsuki · 1 shared paper, 2014 · strength 0.04
  10. Heinz‐Josef Lenz · 1 shared paper, 2014 · strength 0.04
  11. Ramesh K. Ramanathan · 1 shared paper, 2014 · strength 0.04
  12. Syma Iqbal · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.